Analysis of Neuromodulation as a Complementary Treatment to Evidence-based Clinical Intervention in Subjects With Musculoskeletal Pathology of the Lower Limb: a Double-blind Randomized Clinical Trial | Elite Sports MagSkip to content
Analysis of Neuromodulation as a Complementary Treatment to Evidence-based Clinical Intervention in Subjects With Musculoskeletal Pathology of the Lower Limb: a Double-blind Randomized Clinical Trial
The Training Science Trials Ledger follows ClinicalTrials.gov studies of exercise and training interventions, with training and population families, randomization and sponsor flags and completion horizons, drawn from the public ClinicalTrials.gov API and refreshed weekly. Entries summarize registered studies; no medical advice is given or implied.
Analysis of Neuromodulation as a Complementary Treatment to Evidence-based Clinical Intervention in Subjects With Musculoskeletal Pathology of the Lower Limb: a Double-blind Randomized Clinical Trial
Status
NOT_YET_RECRUITING
Training Family
mind-body / mobility
Population Family
clinical population
Is Recruiting
true
Analysis of Neuromodulation as a Complementary Treatment to Evidence-based Clinical Intervention in Subjects With Musculoskeletal Pathology of the Lower Limb: a Double-blind Randomized Clinical Trial
The Training Science Trials Ledger follows ClinicalTrials.gov studies of exercise and training interventions, with training and population families, randomization and sponsor flags and completion horizons, drawn from the public ClinicalTrials.gov API and refreshed weekly. Entries summarize registered studies; no medical advice is given or implied.
Analysis of Neuromodulation as a Complementary Treatment to Evidence-based Clinical Intervention in Subjects With Musculoskeletal Pathology of the Lower Limb: a Double-blind Randomized Clinical Trial